Overview
This is a clinical trial to evaluate the effects of universal screening for diabetic retinopathy (DR) and diabetic macular edema (DME) using artificial intelligence (AI) in the interpretation of fundus photographs obtained by trained nursing assistant using a portable fundus camera in a primary care setting, compared with images obtained by the same method, but interpreted by ophthalmologists.
Eligibility
Inclusion Criteria:
- Adults (\> 18 years old) diagnosed with diabetes mellitus who agree to participate in the study.
Exclusion Criteria:
- Any contraindication for pharmacological mydriasis (such as knowledge of having closed-angle glaucoma, pregnancy).
- Life expectancy less than 6 months